Aurinia Pharmaceuticals (AUPH) Other Working Capital Changes (2024 - 2026)

Aurinia Pharmaceuticals (AUPH) has 7 years of Other Working Capital Changes data on file, last reported at $1.1 million in Q1 2026.

• Quarterly Other Working Capital Changes fell 75.1% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.1 million (down 213.02% YoY) and the FY2025 annual result came in at -$802000.0, down 6.93% from the prior year.
• Other Working Capital Changes grew to $1.1 million in Q1 2026, from -$202000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $4.3 million in Q1 2025 to a low of -$5.7 million in Q3 2025.
• A 5-year average of $112000.0 and a median of -$174000.0 in 2023 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 144833.33% in 2025, down 3006.49% in 2025.
• Tracing AUPH's Other Working Capital Changes over 5 years: stood at $3.6 million in 2022, then slumped by 104.83% to -$174000.0 in 2023, then fell by 14.94% to -$200000.0 in 2024, then fell by 1.0% to -$202000.0 in 2025, then surged by 635.15% to $1.1 million in 2026.
• The last three Other Working Capital Changes figures came in at $1.1 million (Q1 2026), -$202000.0 (Q4 2025), and -$5.7 million (Q3 2025), per Business Quant data.